Justin J. File, Chief Financial Officer at Evofem Biosciences, Inc. (EVFM), sold 1,648 shares at $6.00 ($10K) on 2020-01-13, disclosed to the SEC on 2020-01-15.
Scheduled sale ($10k) by Chief Financial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| EVFM | BUY | 2020-11-18 | $17K | — | Filing → |
| EVFM | BUY | 2020-06-15 | $27K | — | Filing → |
| EVFM | SELL | 2020-01-06 | $20K | — | Filing → |